Literature DB >> 20580415

Development and preliminary evaluation of the KIDCLOT PAC QL: a new health-related quality of life measure for pediatric long-term anticoagulation therapy.

A A K Bruce1, M E Bauman, K Black, A Newton, L Legge, M P Massicotte.   

Abstract

UNLABELLED: Long term anticoagulation (LTA) is hypothesized to induce treatment dissatisfaction influence quality of life (QOL). QOL is measured by a tool developed specific to the patient condition. Pediatric QOL inventory for children on LTA should assess constructs salient for this population. Identification and evaluation of QOL constructs, critical to improve care, and is accepted as the "gold-standard" measurement for patient-centered outcomes in clinical research.
OBJECTIVES: To develop and preliminarily validate a pediatric QOL inventory for children/families receiving LTA. Secondary objective was to determine how anticoagulation disrupts children's life.
METHODS: Stage 1: Item/theme generation through focus groups and existing inventories, Stage 2: Item reduction, inventory generation and content validity. Stage 3: Inventory refinement, implementation and reliability testing. Responses were evaluated for variability, internal consistency, and scale structure. Item reduction was based on response rate, item variability, and clinical utility.
RESULTS: Two inventories, KIDCLOT-PAC-Child -Tween QL and KIDCLOT-PAC Parent-proxy-QL were developed. Content and face validity was assessed by experts, parents, and patients. Internal consistency determined by Cronbach's alpha was good for parent-proxy(0.82) and child(0.89). Pearson correlation was acceptable with >0.5 for test-retest reliability (parent inventory).
CONCLUSIONS: KIDCLOT-PAC-QL is the first preliminarily validated inventory to assess QOL in anticoagulated children. The inventory identifies barriers in care and areas for improvement in order to modify care to provide the "best" management (improved QOL associated with safety and efficacy) for children requiring LTA. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20580415     DOI: 10.1016/j.thromres.2010.05.026

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  3 in total

1.  A multi-national trial of a direct oral anticoagulant in children with cardiac disease: Design and rationale of the Safety of ApiXaban On Pediatric Heart disease On the preventioN of Embolism (SAXOPHONE) study.

Authors:  R Mark Payne; Kristin M Burns; Andrew C Glatz; Danshi Li; Xiaodong Li; Paul Monagle; Jane W Newburger; Elizabeth A Swan; Olivia Wheaton; Christoph Male
Journal:  Am Heart J       Date:  2019-08-09       Impact factor: 4.749

Review 2.  International normalized ratio self-testing and self-management: improving patient outcomes.

Authors:  Matteo Pozzi; Julia Mitchell; Anna Maria Henaine; Najib Hanna; Ola Safi; Roland Henaine
Journal:  Vasc Health Risk Manag       Date:  2016-10-12

3.  A Systematic Review of the Use and Quality of Qualitative Methods in Concept Elicitation for Measures with Children and Young People.

Authors:  Samantha Husbands; Paul Mark Mitchell; Joanna Coast
Journal:  Patient       Date:  2020-06       Impact factor: 3.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.